| Not Yet Recruiting | The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV NCT07466836 | Tyson Perez, DC, PhD | N/A |
| Not Yet Recruiting | C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the Unite NCT07520188 | UNC Lineberger Comprehensive Cancer Center | — |
| Not Yet Recruiting | HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics NCT07089966 | University of Washington | N/A |
| Recruiting | A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) NCT07071623 | Merck Sharp & Dohme LLC | Phase 3 |
| Recruiting | Voluntary HIV Screening in the General Population in France NCT07418385 | Université de Reims Champagne-Ardenne | — |
| Recruiting | Reducing Systemic Inflammation in People on Antiretroviral Therapy NCT07030920 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 |
| Recruiting | Quitting Matters Human Immunodeficiency Virus Hybrid Trial NCT06883097 | Wake Forest University Health Sciences | N/A |
| Recruiting | A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) NCT07044297 | Merck Sharp & Dohme LLC | Phase 3 |
| Recruiting | Project neuroARTEMIS NCT06814275 | Wake Forest University Health Sciences | N/A |
| Recruiting | The Trans-Led Care Study NCT06880705 | Illinois Institute of Technology | N/A |
| Recruiting | Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking C NCT06598397 | New York University | Phase 4 |
| Recruiting | Persuasive Health Communication Intervention for HIV/HCV NCT05968573 | University of South Florida | N/A |
| Completed | A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE) NCT06783192 | Merck Sharp & Dohme LLC | Phase 1 |
| Active Not Recruiting | Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk NCT05657106 | April M Young | N/A |
| Unknown | Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections NCT05727033 | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | N/A |
| Completed | e-HERO: Ending the HIV Epidemic in Rural Oklahoma NCT05664802 | Northern Arizona University | N/A |
| Completed | Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adult NCT05423418 | U.S. Army Medical Research and Development Command | Phase 1 |
| Completed | A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet NCT05197075 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body o NCT04554966 | AbbVie | Phase 1 |
| Completed | Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) NCT04799353 | AbbVie | Phase 1 |
| Unknown | Community Based Screening for HIV Self Testing in FSW in 23 Priority Districts in Indonesia NCT04578145 | Kerti Praja Foundation | N/A |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Parti NCT04223804 | AbbVie | Phase 1 |
| Completed | POC Strategies to Improve TB Care in Advanced HIV Disease NCT04122404 | University of Southern Denmark | N/A |
| Completed | Alcohol Monitor Validation NCT03617705 | University of Florida | N/A |
| Completed | Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy NCT03783130 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents NCT03800394 | University of Florida | — |
| Completed | Mitochondria in HIV and Aging (MITO+) NCT03489421 | University of Colorado, Denver | — |
| Completed | An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricita NCT03577470 | Janssen-Cilag S.p.A. | — |
| Completed | Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux NCT03290755 | University Hospital, Bordeaux | — |
| Completed | The Effect of Ixazomib on the Latent HIV Reservoir NCT02946047 | Mayo Clinic | Phase 1 / Phase 2 |
| Terminated | NC Young Women's CoOp NCT02965014 | RTI International | N/A |
| Completed | Romidepsin Plus 3BNC117 Phase 2a Study NCT02850016 | Rockefeller University | Phase 2 |
| Terminated | An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study NCT02990858 | CytoDyn, Inc. | Phase 2 / Phase 3 |
| Completed | Cape Town Young Women's Health CoOp NCT02974998 | RTI International | N/A |
| Completed | New Strategies to Assess Anal Cancer Risk In Women NCT02873741 | Emory University | — |
| Completed | 3BNC117 and 10-1074 in HIV-infected Individuals NCT02825797 | Rockefeller University | Phase 1 |
| Unknown | Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Vir NCT02511496 | Maimónides Biomedical Research Institute of Córdoba | — |
| Completed | Tesamorelin Effects on Liver Fat and Histology in HIV NCT02196831 | Massachusetts General Hospital | N/A |
| Terminated | CPAP Improving Mortality for Pneumonia in African Children Trial NCT02484183 | Johns Hopkins University | N/A |
| Completed | Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficie NCT02403674 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Regular HIV Testing Among At-Risk Latino Men NCT02454725 | Medical College of Wisconsin | N/A |
| Completed | A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infe NCT02388594 | University of Pennsylvania | Phase 1 |
| Completed | Pericardial Fat and Inflammation in HIV Patients and Controls NCT02399384 | University of Cincinnati | — |
| Completed | Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophyl NCT02165202 | PATH | Phase 2 |
| Completed | The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients NCT02234492 | Ottawa Heart Institute Research Corporation | Phase 4 |
| Completed | Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART NCT02225665 | Sangamo Therapeutics | Phase 1 / Phase 2 |
| Completed | Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting NCT02037594 | Hunter College of City University of New York | N/A |
| Completed | Enhanced HIV Prevention in Couples: Feasibility Study #3 NCT02027519 | Columbia University | — |
| Unknown | Assessment of Group Peer Support to Children With HIV in Vietnam NCT02035969 | Karolinska Institutet | N/A |
| Completed | Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected NCT02474901 | University of Colorado, Denver | Phase 2 |
| Completed | Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents NCT01849393 | St. Jude Children's Research Hospital | — |
| Completed | Enhanced Prevention in Couples: Feasibility Study #2 NCT02027441 | Columbia University | — |
| Completed | Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults NCT01685372 | University of Colorado, Denver | Phase 2 |
| Completed | Multi-level Determinants of Starting ART Late: Aim 3 NCT01997359 | Columbia University | — |
| Completed | Pediatric Enhanced Surveillance Study NCT02043769 | Columbia University | — |
| No Longer Available | Compassionate Use of Ibalizumab for the Treatment of HIV Infection NCT02028819 | University of Colorado, Denver | — |
| Completed | An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART NCT01541085 | Janssen-Cilag S.p.A. | — |
| Completed | Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) NCT01516970 | Janssen-Cilag G.m.b.H | Phase 3 |
| Completed | Multi-level Determinants of Starting ART Late: Aim 2 NCT01997346 | Columbia University | — |
| Completed | An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients NCT01615601 | Janssen Inc. | — |
| Completed | A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) NCT01449006 | Bruce Brew | Phase 4 |
| Terminated | A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV NCT01448486 | St Vincent's Hospital, Sydney | Phase 4 |
| Completed | Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men NCT02572401 | University of Pennsylvania | N/A |
| Completed | Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women NCT01385241 | Duke University | N/A |
| Completed | Enhanced HIV Prevention in Couples: Feasibility Study #1 NCT02027714 | Columbia University | — |
| Completed | The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System NCT01206933 | George Washington University | — |
| Unknown | Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/ NCT01875952 | Instituto Nacional de Salud Publica, Mexico | Phase 4 |
| Completed | A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment NCT01199939 | Tibotec, Inc | Phase 2 |
| Completed | Study of Vitamin D and Effect on Heart Disease and Insulin Resistance NCT01093417 | University Hospitals Cleveland Medical Center | Phase 2 |
| Completed | A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Com NCT01045317 | Pfizer | Phase 1 |
| Completed | Impact of Nutrition Intervention on HIV/AIDS Infected Patients NCT01171495 | Caribbean Health Research Council | Phase 3 |
| Completed | Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission NCT01053741 | Johns Hopkins University | N/A |
| Unknown | Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure NCT01433601 | Karolinska Institutet | N/A |
| Completed | ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens NCT00335322 | Kirby Institute | Phase 4 |
| Completed | SPL7013 Gel - Male Tolerance Study NCT00370357 | Starpharma Pty Ltd | Phase 1 |
| Completed | A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immun NCT03407105 | Bristol-Myers Squibb | Phase 1 |
| No Longer Available | A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Com NCT00992654 | ViiV Healthcare | — |